Using approved MS drug Copaxone during pregnancy or breastfeeding does not appear to raise the risk of problems for the child ...

People who use drugs are members of our communities and equally deserve protection from crime; OPCs are often a safe haven ...

Think you're using real Ozempic? Think again. Fake versions are everywhere—dangerous, unregulated, and often mislabeled.

Regeneron’s Eylea franchise remains resilient despite biosimilar competition. Read what makes REGN stock a Strong Buy despite ...

North Dakota Health and Human Services (HHS) has opened applications for grant funding through the state’s opioid settlement ...

Inebilizumab-cdon was previously approved by the FDA for neuromyelitis optica spectrum disorder (NMOSD) in adults who are ...

Two skunks tested positive for rabies in Mechanicsville, prompting health officials to urge residents to avoid wild animals ...

Fitusiran is a small interference RNA therapeutic designed to prevent bleeds in patients with hemophilia A or B by lowering antithrombin.

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the new Donald Trump administration. Health care stocks can often be a solid defensive play in an uncertain economy.

The harm reduction initiative is not funded by the US, but it is now competing for scarce local resources. View on euronews ...

The Public Health Committee of the state legislature is advancing a bill proposal that could establish opioid overdose ...

PRETORIA, South Africa (AP) — A secluded corner surrounded by litter and makeshift structures on the outskirts of South ...